CAS 843663-66-1,Bedaquiline (TMC-207;TMC207;TMC 207)

Basic Info

Model No.: 843663-66-1

Function: Nutritional Therapeutics

Grade Standard: Medicine Grade

State: Solid

Volatile: Not Volatile

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

Beidaquinoline Cas Number 843663-66-1 referred to as TMC-207. It is a new anti-tuberculosis drug, which has been declared registration in China currently. The more optimistic estimate is that the drug may be approved before September 2016 on listed. it was approved for the first anti-TB drug nearly 40 years, the main mechanism is the inhibition of Mycobacterium tuberculosis ATPase, blocking the energy supply of bacteria, Strains have the same bactericidal activity, and without cross-resistance to the existing anti-TB drugs , As the evolution of tuberculosis, depends on a new drug is not enough in future, may also need several new drugs together to form a new treatment program.

Thera. Category:Anti-tuberculosis 

Cas No.:  843663-66-1 

Synonym:TMC-207;Bedaquiline(R 207910,TMC 207);Bedaquiline (TMC-207);6-Bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol;1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol;3-Quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-, (alphas,betar)-;R 207910;Bedaquiline;

Molecular Weight: 525.487

Molecular formula: C31H29BrN2O

Purity: ≥99.%

Packing:Export worthy packing

Material Safety Data Sheet:Available on request